Novartis AG R&D Day (Virtual) Transcript
Good morning, good afternoon, ladies and gentlemen, and welcome to the Novartis R&D Day 2021. (Operator Instructions) And the event is being recorded. (Operator Instructions) A recording of the full event will be available on our website shortly after it ends.
With that, I would now like to hand over to Samir Shah, Global Head of Investor Relations. Please go ahead.
Thank you very much, and good morning and good afternoon to everybody. A big welcome and thank for taking part in this R&D event from Novartis. The information presented today contains forward-looking statements that involve known and unknown risks, uncertainties and other factors. These may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. For a description of some of these factors, please refer to the company's Form 20-F and its most recent quarterly results on Form 6-K that respectively were filed with and furnished to the U.S. Securities and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |